PTLA
Portola Pharmaceuticals, Inc.
PTLA
PTLA
Delisted
PTLA was delisted on the 1st of July, 2020.
180 hedge funds and large institutions have $1.92B invested in Portola Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 51 increasing their positions, 49 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
180
Holders Change
+30
Holders Change %
+20%
% of All Funds
4.49%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.15%
New
52
Increased
51
Reduced
49
Closed
14
Calls
$39.4M
Puts
$19.4M
Net Calls
+$20.1M
Net Calls Change
+$11.1M
Top Buyers
| 1 |
BlackRock
New York
|
+$158M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$43.7M |
| 3 |
CCM
Cadian Capital Management
New York
|
+$34M |
| 4 |
FAM
Fred Alger Management
New York
|
+$28.6M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$24.9M |
Top Sellers
| 1 |
DM
Deerfield Management
New York
|
-$126M |
| 2 |
Millennium Management
New York
|
-$34.4M |
| 3 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$32M |
| 4 |
Morgan Stanley
New York
|
-$22.2M |
| 5 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$15.4M |
